abstract |
THE COMPOUNDS DESCRIBED HEREIN REFER TO THE TREATMENT OF DIABETES AND / OR HYPERGLYCAEMIA. MORE PARTICULARLY +, THE DESCRIBED COMPOUNDS REFER TO ACILLATED INSULIN COMPOUNDS THAT REDUCE GLUCOSE IN BLOOD, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS, THERAPEUTIC USES OF SUCH COMPOUNDS, AND AN INTERMEDIATE COMPOUND FOR THE INTERMEDIATE USER OF COMPUTERS. |